Showing 1 - 5 results of 5 for search 'Maykel Cerdas', query time: 0.03s Refine Results
  1. 1
    Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea.

    Preclinical evaluation of caprylic acid-fractionated IgG antivenom for the treatment of Taipan (Oxyuranus scutellatus) envenoming in Papua New Guinea. by Mariángela Vargas, Alvaro Segura, María Herrera, Mauren Villalta, Ricardo Estrada, Maykel Cerdas, Owen Paiva, Teatulohi Matainaho, Simon D Jensen, Kenneth D Winkel, Guillermo León, José María Gutiérrez, David J Williams

    Published 2011-05-01
    Get full text
    Article
  2. 2
    Pilot-scale evaluation of a dynamic body-feed filtration system for primary clarification of snake antivenoms produced by the caprylic acid method

    Pilot-scale evaluation of a dynamic body-feed filtration system for primary clarification of snake antivenoms produced by the caprylic acid method by Andrés Sánchez, Maykel Cerdas, Jairo Gutiérrez, Mariángela Vargas, Álvaro Segura, María Herrera, Stephanie Chaves-Araya, Ronald Sánchez, Mauren Villalta, Gina Durán, Adriana Sánchez, Gabriela Solano, Daniel Cordero, Paola Sánchez, José María Gutiérrez, Guillermo León

    Published 2024-09-01
    Get full text
    Article
  3. 3
    A polygeneric immunogen composed of 22 venoms from sub-Saharan African snakes to expand the neutralization scope of the EchiTAb-plus-ICP antivenom

    A polygeneric immunogen composed of 22 venoms from sub-Saharan African snakes to expand the neutralization scope of the EchiTAb-plus-ICP antivenom by Andrés Sánchez, Gina Durán, Maykel Cerdas, Jairo Gutiérrez, Álvaro Segura, María Herrera, Mariángela Vargas, Adriana Sánchez, Paola Sánchez, Gabriela Solano, Mauren Villalta, Edwin Moscoso, Deibid Umaña, Mauricio Arguedas, Aarón Gómez, José María Gutiérrez, Guillermo León

    Published 2024-12-01
    Get full text
    Article
  4. 4
    Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

    Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19 by Guillermo León, María Herrera, Mariángela Vargas, Mauricio Arguedas, Andrés Sánchez, Álvaro Segura, Aarón Gómez, Gabriela Solano, Eugenia Corrales-Aguilar, Kenneth Risner, Aarthi Narayanan, Charles Bailey, Mauren Villalta, Andrés Hernández, Adriana Sánchez, Daniel Cordero, Daniela Solano, Gina Durán, Eduardo Segura, Maykel Cerdas, Deibid Umaña, Edwin Moscoso, Ricardo Estrada, Jairo Gutiérrez, Marcos Méndez, Ana Cecilia Castillo, Laura Sánchez, Ronald Sánchez, José María Gutiérrez, Cecilia Díaz, Alberto Alape

    Published 2021-05-01
    Get full text
    Article
  5. 5
    In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar Formulation Produced From Plasma of COVID-19 Convalescent Donors

    In vitro Characterization of Anti-SARS-CoV-2 Intravenous Immunoglobulins (IVIg) Produced From Plasma of Donors Immunized With the BNT162b2 Vaccine and Its Comparison With a Similar... by Gabriel Rojas-Jiménez, Daniela Solano, Álvaro Segura, Andrés Sánchez, Stephanie Chaves-Araya, María Herrera, Mariángela Vargas, Maykel Cerdas, Gerardo Calvo, Jonathan Alfaro, Sebastián Molina, Kimberly Bolaños, Andrés Moreira-Soto, Andrés Moreira-Soto, Mauren Villalta, Adriana Sánchez, Daniel Cordero, Gina Durán, Gabriela Solano, Aarón Gómez, Andrés Hernández, Laura Sánchez, Marco Vargas, Jean Felix Drexler, Jean Felix Drexler, Alberto Alape-Girón, Alberto Alape-Girón, Cecilia Díaz, Cecilia Díaz, Guillermo León

    Published 2022-01-01
    Get full text
    Article

Search Tools: